Content about Latest News

CINCINNATI — Part of its 50th anniversary as a baby care brand, Pampers has launched its Little Miracle Missions program.

NORTHRIDGE, Calif. — Pharmavite on Monday named Bill Tullis as its new EVP sales.

Tullis comes to Pharmavite with more than 25 years of experience within the consumer packaged goods industry, most recently as area VP for alternate channels at Del Monte Foods. Prior to his work at Del Monte Foods, Tullis held sales and marketing positions at Nabisco and Nestle USA.

PARIS — Genzyme now officially is a wholly owned subsidiary of Sanofi-Aventis.

The Paris-based drug maker said that the closing followed the completion of the exchange offer for drug maker Genzyme last week. As its subsidiary, Genzyme will become a new platform in Sanofi's sustainable growth strategy and expand the company's presence in biotechnology, Sanofi said. Genzyme will continue to operate out of its Cambridge, Mass., headquarters, and will be led by Sanofi CEO Christopher Viehbacher for several months.

BENTONVILLE, Ark. — Walmart is looking to distinguish itself from the competition.

The retailer announced that it is reinvigorating its price leadership promise, bringing back products its customers have asked for and simplifying its ad match policy.

FRISCO, Texas — Specialty pharmacy provider Assured Pharmacy will reduce its stock through a reverse stock split, the company said Thursday.

The company, which trades on the pink sheets but seeks to eventually be listed on a larger exchange, announced that it had filed an amendment to its articles of incorporation whereby it would convert every 180 shares of stock to a single stock, reducing the total number of shares of outstanding common stock from 416,200,000 to 2,321,222, while reducing authorized shares of common stock from 3 billion to 16,666,667.

BIRMINGHAM, Ala. — A grape soda brand has gotten a makeover.

Buffalo Rock Bottling, a privately held PepsiCo bottler, said that its Grapico and Diet Grapico cans now feature a multi-hued purple emblem, product wording in a signature Southern block script and a cluster of purple grapes at the top.

The packaging redesign applies to all versions of the soft drink, including the 2-liters, 20-oz. single-serving bottles, 12-oz. cans and 12-pack cartons.

Grapico is a well-known staple in the South and made its debut in New Orleans in 1914.

AMITYVILLE, N.Y. — The Food and Drug Administration has granted tentative approval to a generic antibiotic made by Hi-Tech Pharmacal, the drug maker said Friday.

Hi-Tech announced the tentative approval of levofloxacin oral solution in the 25 mg-per-mL strength. The drug is used to treat mild, moderate and severe bacterial infections in adults.

HAYWARD, Calif., and HIGH POINT, N.C. — Impax Labs will collaborate with a specialty pharmaceutical company dedicated to the research, development and manufacturing of unique gelatin-based dosage forms.

Impax said it has entered a deal with Banner Pharmacaps in respect to the supply and commercialization of two softgel capsule products.

The products and terms of the agreement were not disclosed.

NEW YORK — A line of inflatable inserts that prevent boots from wrinkling and creasing have gained distribution in Duane Reade.

Booty Shapers offer consumers an inexpensive way to store boots and are available in small, medium and large sizes, catering to all different kinds of boots, the company said.

Booty Shapers can be purchased at Duane Reade, CVS.com, Drugstore.com and more, for a suggested retail price of $9.99 per pair.

ALEXANDRIA, Va. — A Georgetown University Health Policy Institute study of Florida’s Medicaid Managed Care pilot program should raise doubts for states considering the use of for-profit managed care companies to reduce Medicaid costs, the National Community Pharmacists Association cautioned on Friday.

CINCINNATI — Procter & Gamble has announced a voluntary recall of 10 shades of its Clairol Natural Instincts in the United States, Canada and Puerto Rico because of a mismatched ColorFresh! Revitalizer sachet in the kits that may create an unwanted color result.

TARRYTOWN, N.Y. and BERLIN — Regeneron and Bayer HealthCare have initiated 1-of-2 late-stage clinical trials of their aflibercept ophthalmic solution in the treatment of a complication caused by diabetic retinopathy.

The drug makers said that it would evaluate the efficacy of VEGF Trap-Eye (aflibercept ophthalmic solution) in the treatment of diabetic macular edema, a prevalent cause of vision loss among diabetes patients, after promising results from its previous clinical trial.